These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21979992)

  • 1. Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure.
    Gudmundsson K; Lyngå P; Karlsson H; Rosenqvist M; Braunschweig F
    Eur J Heart Fail; 2011 Nov; 13(11):1172-7. PubMed ID: 21979992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT; Compton S; Haas G; Foreman B; Canby RC; Fishel R; McRae S; Toledo GB; Sarkar S; Hettrick DA;
    Congest Heart Fail; 2011; 17(2):51-5. PubMed ID: 21449992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
    Gudmundsson K; Lyngå P; Rosenqvist M; Braunschweig F
    Clin Cardiol; 2016 Aug; 39(8):446-52. PubMed ID: 27175605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.
    Maines M; Catanzariti D; Cirrincione C; Valsecchi S; Comisso J; Vergara G
    Europace; 2010 May; 12(5):680-5. PubMed ID: 20047927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical link between heart failure self-care and intrathoracic impedance.
    Rathman LD; Lee CS; Sarkar S; Small RS
    J Cardiovasc Nurs; 2011; 26(4):E20-6. PubMed ID: 21076309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
    Whellan DJ; Droogan CJ; Fitzpatrick J; Adams S; McCarey MM; Andrel J; Mather P; Rubin S; Bonita R; Keith S
    J Card Fail; 2012 Feb; 18(2):107-12. PubMed ID: 22300777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
    Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
    Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual cause of OptiVol alarm: increased intra-abdominal pressure associated with irritable bowel syndrome.
    Türkoğlu C; Aliyev F; Celiker C; Cetin G
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):403-6. PubMed ID: 20019454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.